Poland· PL-100429266

Axotonil Max

A other otologicals product containing cholini salicylas, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o..

ATC S02D

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAxotonil MaxATCS02DREGISTER NO.PL-100429266PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Cholini salicylas
Manufacturer
Aflofarm Farmacja Polska Sp. z o.o.
Country
Poland (PL)
ATC code
S02D
ATC class
OTHER OTOLOGICALS
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991466510

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cholini salicylas in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cholini salicylas products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd2e1359-2acf-40e0-96a5-f217bf160228
GET /v1/drugs/cd2e1359-2acf-40e0-96a5-f217bf160228?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol do uszu, roztwór",
  "source": "urpl",
  "strength": "440 mg/ml",
  "packaging": "05909991466510 ¦ OTC ¦ 142025\n1 butelka 10 ml",
  "substance": "Cholini salicylas 440 mg/ml",
  "common_name": "Cholini salicylas",
  "pl_product_id": "100429266",
  "pozwolenie_nr": "26656",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about cholini salicylas.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.